查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
鼻腔給藥技術市場規模、份額和趨勢分析報告：按劑型、容器類型、治療用途、分銷渠道、地區、細分市場，2023-2030 年
市場調查報告書
商品編碼
1178594

鼻腔給藥技術市場規模、份額和趨勢分析報告：按劑型、容器類型、治療用途、分銷渠道、地區、細分市場，2023-2030 年

Nasal Drug Delivery Technology Market Size, Share & Trends Analysis Report By Dosage Form, By Container Type, By Therapeutic Application, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 185 Pages | 商品交期: 2-10個工作天內

價格

鼻腔給藥技術市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，2022 年全球鼻腔給藥技術市場規模將達到 1271.2 億美元，2023 年至 2030 年的複合年增長率為 7.45%。鼻腔產品意識的增強是推動市場的主要因素之一。

人口老齡化加劇預計將積極推動整個市場。根據聯合國經濟和社會事務部的一份報告，到2020年，全球65歲及以上的人口將達到7.27億。未來 30 年，世界老年人口預計將翻一番以上，到 2050 年將超過 15 億。從 2020 年到 2050 年，預計全國老年人口將增加。在全球範圍內，65 歲及以上人口的比例預計將從 2020 年的 9.3% 上升到 2050 年的近 16.0%。

此外，由於鼻腔製劑的功效和易於給藥，患者對鼻腔製劑的偏好不斷增加，預計也將促進鼻腔給藥系統市場的增長。例如，2021 年 2 月，芬蘭公司 Nanoform 和 Herantis 就概念驗證制定工作達成了一項非排他性協議，並宣布了一項向大腦輸送鼻腔藥物的協議。

此外，經鼻給藥方式具有為藥物提供全身循環途徑、生物利用度低、吸收快、作用良好等優點，廣泛應用於腦部疾病的治療。在這方面，鼻腔給藥可以作為一種有吸引力的中樞神經系統藥物非侵入性給藥方法。此外，鼻內遞送類□、雷替曲塞、5-氟尿嘧啶端粒□抑製劑和甲氨蝶呤等物質已被證明可以減少腦腫瘤並增加動物模型的存活率。

鼻腔給藥技術市場報告重點

從劑型來看，由於傳染病和過敏性鼻炎發病率的增加，以及對仿製藥鼻噴霧劑藥物的需求，鼻噴霧劑領域將在2022年佔銷售額的最大份額。

按容器類型劃分，非壓力容器部分在 2022 年佔據市場主導地位。滴鼻劑、鼻粉和鼻凝膠通常裝在這些容器中。相關產品需求的增長預計將在預測期內推動該細分市場的增長

通過治療應用，由於治療鼻炎的相關產品的可用性，鼻炎部分將在 2022 年佔據最大份額。

按銷售渠道劃分，由於容易獲得和方便，零售藥店將在 2022 年佔據最大份額

由於哮喘和慢性阻塞性肺病患病率上升以及早期治療的廣泛使用，北美將在 2022 年佔據最高市場份額

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
    • 劑型
    • 集裝箱類型
    • 治療應用
    • 分銷渠道
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 第一次調查的內容
      • 北美初級面試數據
      • 歐洲初級訪談數據
      • 來自亞太地區的主要訪談數據
      • 來自拉丁美洲的初步訪談數據
      • 來自 MEA 初步訪談的數據
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析（模型一）
      • 方法一：商品流動方法
    • 量價分析（模型二）
      • 方法二：量價分析
  • 二級信息列表
  • 縮略語表
  • 目的

第二章執行摘要

  • 市場展望

3. 鼻腔給藥技術市場變量、趨勢和範圍

  • 繪製滲透率和增長前景
  • 市場動態
    • 市場驅動力分析
      • 患者越來越喜歡經鼻給藥
      • 慢性病發病率增加
      • 更多地採用自我管理實踐
      • 開髮用於呼吸治療的非專利藥物
    • 市場約束因素分析
      • 與過度使用鼻腔噴霧劑相關的並發症
      • 嚴格的監管框架
  • 鼻腔給藥技術：一種市場分析工具
    • PESTEL 的 SWOT 分析
    • 行業分析——波特五力
  • COVID-19 的影響
    • COVID-19 影響分析
    • 對市場參與者的影響

4 鼻腔給藥技術市場：細分分析，按劑型，2018-2030 年（十億美元）

  • 定義和範圍
  • 劑型市場份額分析
  • 細分儀表板
  • 鼻腔給藥技術市場，按劑型分類
  • 市場規模和預測，趨勢分析，2018-2030
    • 噴鼻劑
    • 滴鼻劑
    • 鼻凝膠
    • 滴鼻劑

5 鼻腔給藥技術市場：細分分析，按容器類型，2018-2030 年（十億美元）

  • 定義和範圍
  • 集裝箱類型市場份額分析
  • 細分儀表板
  • 鼻腔給藥技術市場，按容器類型
  • 市場規模和預測，趨勢分析，2018-2030
    • 壓力容器
    • 常壓容器

6. 鼻腔給藥技術市場：細分分析，按治療用途，2018-2030 年（十億美元）

  • 定義和範圍
  • 治療應用的市場份額分析
  • 細分儀表板
  • 鼻腔給藥技術市場，按治療用途分類
  • 市場規模和預測，趨勢分析，2018-2030
    • 鼻塞
    • 鼻炎
    • 哮喘
    • 其他

7 鼻腔給藥技術市場：細分分析，按分銷渠道，2018-2030 年（十億美元）

  • 定義和範圍
  • 分銷渠道市場份額分析
  • 細分儀表板
  • 鼻腔給藥技術市場，按分銷渠道
  • 市場規模和預測，趨勢分析，2018-2030
    • 醫院藥房
    • 零售藥店
    • 網上藥店
    • 其他

8. 鼻腔給藥技術市場：區域市場分析，2018-2030（十億美元）

  • 區域市場儀表板
  • 定義和範圍
  • 區域市場份額分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
    • 泰國
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第 9 章鼻腔給藥技術市場——競爭分析

  • 衝突類型
  • 市場主體集中
  • 公司市場份額分析
  • 基於企業願景的分類
  • 公司簡介
    • GlaxoSmithKline PLC
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • AstraZeneca PLC
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Pfizer, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • OptiNose, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Becton, Dickinson and Company
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Promius Pharma, LLC
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Cadila Pharmaceuticals Ltd.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • BF Ascher &Company, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • PendoPharm, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Douglas Pharmaceuticals Ltd.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • ENT Technologies Pty. Ltd.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • ENT Technologies Pty. Ltd.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
Product Code: GVR-2-68038-740-7

Nasal Drug Delivery Technology Market Growth & Trends:

The global nasal drug delivery technology market was valued at USD 127.12 billion in 2022, expanding at a CAGR of 7.45% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growing awareness regarding nasal products is one of the major factors driving the market.

The growing geriatric population is expected to positively drive the overall market. In 2020, there were 727 million people worldwide who are 65 years of age or older, according to a report by the United Nations Department of Economic and Social Affairs. The number of elderly people worldwide is expected to depict more than double growth during the next three decades, reaching over 1.5 billion in 2050. Between 2020 and 2050, the geriatric population is expected to grow in size across the nation. Globally, it is anticipated that the percentage of people 65 and older will rise from 9.3% in 2020 to almost 16.0% in 2050.

Moreover, increasing patient preference for nasal products owing to their efficacy and easy administration is anticipated to fuel the nasal drug delivery systems market growth. For instance, in February 2021, Nanoform Finland and Herantis announced their agreement on nasal drug delivery to the brain by creating a non-exclusive agreement for formulation proof of concept initiatives.

Additionally, the nasal drug delivery method is widely used to treat brain disorders as it offers a route for systemic circulation of drugs, low bioavailability, fast absorption, and desirable action. In this respect, nasal drug delivery could serve as an attractive non-invasive delivery method for CNS drugs. Moreover, nasal delivery of substances such as peptoids, raltitrexed, 5-fluorouracil telomerase inhibitors, and methotrexate has been shown to reduce brain tumors and increase survival in animal models.

Nasal Drug Delivery Technology Market Report Highlights:

  • Based on dosage form, the nasal spray segment held the largest revenue share in 2022 owing to the increasing incidence of infections and allergic rhinitis and growing demand for generic nasal spray drugs
  • By container type, the non-pressurized containers segment dominated the market in 2022. Nasal drops, nasal powder, and nasal gel usually come in these containers. Growing demand for related products is expected to propel the segment growth over the forecast period
  • In terms of therapeutic application, the rhinitis segment held the largest share in 2022 due to the availability of related products for its treatment
  • By distribution channel, the retail pharmacies segment accounted for the largest share in 2022 owing to easy availability and convenience
  • North America held the largest market share in 2022 owing to the rising prevalence of asthma and chronic obstructive pulmonary disease and the widespread usage of early treatment measures

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Dosage Form
    • 1.1.2 Container Type
    • 1.1.3 Therapeutic Application
    • 1.1.3 Distribution Channel
    • 1.1.5 Regional Scope
    • 1.1.6 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
      • 1.3.5.1 Data for primary interviews in North America
      • 1.3.5.3 Data for Primary Interviews in Europe
      • 1.3.5.4 Data for Primary Interviews in APAC
      • 1.3.5.6 Data for Primary Interviews in Latin America
      • 1.3.5.8 Data for Primary Interviews in MEA
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume Price Analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume Price Analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3
    • 1.9.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Nasal Drug Delivery Technology Market Variables, Trends & Scope

  • 3.1 Penetration & Growth Prospect Mapping
  • 3.2 Market Dynamics
    • 3.2.1 Market Drivers Analysis
      • 3.2.1.1 Rising patient preference for nasal drug delivery
      • 3.2.1.2 Growing incidence of chronic diseases
      • 3.2.1.3 Increasing adoption of self-administration practices
      • 3.2.1.4 Development of off-patent drugs for respiratory care
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Complications associated with the overuse of nasal sprays
      • 3.2.2.2 Stringent regulatory framework
  • 3.3 Nasal Drug Delivery Technology: Market Analysis Tools
    • 3.3.1 SWOT Analysis by PESTEL
    • 3.3.2 Industry Analysis - Porter's Five Forces
  • 3.4 Impact of COVID-19
    • 3.4.1 COVID-19 Impact analysis
    • 3.4.2 Impact on market players

Chapter 4 Nasal Drug Delivery Technology Market: Segment Analysis, By Dosage Form, 2018 - 2030 (USD Billion)

  • 4.1 Definitions and Scope
  • 4.2 Dosage Form Market Share Analysis
  • 4.3 Segment Dashboard
  • 4.4 Nasal Drug Delivery Technology Market by Dosage Form
  • 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1 Nasal Spray
      • 4.5.1.1 Nasal Spray Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.5.2 Nasal Drop
      • 4.5.2.1 Nasal Drop Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.5.3 Nasal Gel
      • 4.5.3.1 Nasal Gel Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.5.4 Nasal Powder
      • 4.5.4.1 Nasal Powder Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 5 Nasal Drug Delivery Technology Market: Segment Analysis, By Container Type, 2018 - 2030 (USD Billion)

  • 5.1 Definitions and Scope
  • 5.2 Container Type Market Share Analysis
  • 5.3 Segment Dashboard
  • 5.4 Nasal Drug Delivery Technology Market by Container Type
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1 Pressurized Containers
      • 5.5.1.1 Pressurized Containers Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 5.5.2 Non-pressurized Containers
      • 5.5.2.1 Non-pressurized Containers Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 6 Nasal Drug Delivery Technology Market: Segment Analysis, By Therapeutic Application, 2018 - 2030 (USD Billion)

  • 6.1 Definitions and Scope
  • 6.2 Therapeutic Application Market Share Analysis
  • 6.3 Segment Dashboard
  • 6.4 Nasal Drug Delivery Technology Market by Therapeutic Application
  • 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1 Nasal Congestion
      • 6.5.1.1 Nasal Congestion Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 6.5.2 Rhinitis
      • 6.5.2.1 Rhinitis Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 6.5.3 Asthma
      • 6.5.3.1 Asthma Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 6.5.4 Others
      • 6.5.4.1 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 7 Nasal Drug Delivery Technology Market: Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Billion)

  • 7.1 Definitions and Scope
  • 7.2 Distribution Channel Market Share Analysis
  • 7.3 Segment Dashboard
  • 7.4 Nasal Drug Delivery Technology Market by Distribution Channel
  • 7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.5.1 Hospital Pharmacies
      • 7.5.1.1 Hospital Pharmacies Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 7.5.2 Retail Pharmacies
      • 7.5.2.1 Retail Pharmacies Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 7.5.3 Online Pharmacies
      • 7.5.3.1 Asthma Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 7.5.4 Others
      • 7.5.4.1 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 8 Nasal Drug Delivery Technology Market: Regional Market Analysis, 2018 - 2030 (USD Billion)

  • 8.1 Regional Market Dashboard
  • 8.2 Definitions and Scope
  • 8.3 Regional Market Share Analysis
  • 8.4 North America
    • 8.4.1 North America market estimates and forecast, 2018 - 2030
    • 8.4.2 U.S.
      • 8.4.2.1 U.S. market estimates and forecast, 2018 - 2030
    • 8.4.3 Canada
      • 8.4.3.1 Canada market estimates and forecast, 2018 - 2030
  • 8.5 Europe
    • 8.5.1 Europe market estimates and forecast, 2018 - 2030
    • 8.5.2 U.K.
      • 8.5.2.1 U.K. market estimates and forecast, 2018 - 2030
    • 8.5.3 Germany
      • 8.5.3.1 Germany market estimates and forecast, 2018 - 2030
    • 8.5.4 France
      • 8.5.4.1 France market estimates and forecast, 2018 - 2030
    • 8.5.5 Italy
      • 8.5.5.1 Italy market estimates and forecast, 2018 - 2030
    • 8.5.6 Spain
      • 8.5.6.1 Spain market estimates and forecast, 2018 - 2030
    • 8.5.7 Sweden
      • 8.5.7.1 Sweden market estimates and forecast, 2018 - 2030
    • 8.5.8 Denmark
      • 8.5.8.1 Denmark market estimates and forecast, 2018 - 2030
    • 8.5.9 Norway
      • 8.5.9.1 Norway market estimates and forecast, 2018 - 2030
  • 8.6 Asia Pacific
    • 8.6.1 Asia Pacific market estimates and forecast, 2018 - 2030
    • 8.6.2 Japan
      • 8.6.2.1 Japan market estimates and forecast, 2018 - 2030
    • 8.6.3 China
      • 8.6.3.1 China market estimates and forecast, 2018 - 2030
    • 8.6.4 India
      • 8.6.4.1 India market estimates and forecast, 2018 - 2030
    • 8.6.5 Australia
      • 8.6.5.1 Australia market estimates and forecast, 2018 - 2030
    • 8.6.6 South Korea
      • 8.6.6.1 South Korea market estimates and forecast, 2018 - 2030
    • 8.6.7 Thailand
      • 8.6.7.1 Thailand market estimates and forecast, 2018 - 2030
  • 8.7 Latin America
    • 8.7.1 Latin America market estimates and forecast, 2018 - 2030
    • 8.7.2 Mexico
      • 8.7.2.1 Mexico market estimates and forecast, 2018 - 2030
    • 8.7.3 Brazil
      • 8.7.3.1 Brazil market estimates and forecast, 2018 - 2030
    • 8.7.4 Argentina
      • 8.7.4.1 Argentina market estimates and forecast, 2018 - 2030
  • 8.8 Middle East and Africa
    • 8.8.1 Middle East and Africa market estimates and forecast, 2018 - 2030
    • 8.8.2 South Africa
      • 8.8.2.1 South Africa market estimates and forecast, 2018 - 2030
    • 8.8.3 Saudi Arabia
      • 8.8.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030
    • 8.8.4 UAE
      • 8.8.4.1 UAE market estimates and forecast, 2018 - 2030
    • 8.8.5 Kuwait
      • 8.8.5.1 Kuwait market estimates and forecast, 2018 - 2030

Chapter 9 Nasal Drug Delivery Technology Market - Competitive Analysis

  • 9.1 Kind of Competition
  • 9.2 Concentration of Market Players
  • 9.3 Company Market Share Analysis
  • 9.4 Categorization based on the Company's Vision
  • 9.5 Company Profiles
    • 9.5.1 GlaxoSmithKline PLC
      • 9.5.1.1 Company overview
      • 9.5.1.2 Financial performance
      • 9.5.1.3 Product benchmarking
      • 9.5.1.4 Strategic initiatives
    • 9.5.2 AstraZeneca PLC
      • 9.5.2.1 Company overview
      • 9.5.2.2 Financial performance
      • 9.5.2.3 Product benchmarking
      • 9.5.2.4 Strategic initiatives
    • 9.5.3 Pfizer, Inc.
      • 9.5.3.1 Company overview
      • 9.5.3.2 Financial performance
      • 9.5.3.3 Productbenchmarking
      • 9.5.3.4 Strategic initiatives
    • 9.5.4 OptiNose, Inc.
      • 9.5.4.1 Company overview
      • 9.5.4.2 Financial performance
      • 9.5.4.3 Product benchmarking
      • 9.5.4.4 Strategic initiatives
    • 9.5.5 Becton, Dickinson and Company
      • 9.5.5.1 Company overview
      • 9.5.5.2 Financial performance
      • 9.5.5.3 Product benchmarking
      • 9.5.5.4 Strategic initiatives
    • 9.5.6 Promius Pharma, LLC
      • 9.5.6.1 Company overview
      • 9.5.6.2 Financial performance
      • 9.5.6.3 Product benchmarking
      • 9.5.6.4 Strategic initiatives
    • 9.5.7 Cadila Pharmaceuticals Ltd.
      • 9.5.7.1 Company overview
      • 9.5.7.2 Financial performance
      • 9.5.7.3 Product benchmarking
      • 9.5.7.4 Strategic initiatives
    • 9.5.8 B.F. Ascher & Company, Inc.
      • 9.5.8.1 Company overview
      • 9.5.8.2 Financial performance
      • 9.5.8.3 Product benchmarking
      • 9.5.8.4 Strategic initiatives
    • 9.5.9 PendoPharm, Inc.
      • 9.5.9.1 Company overview
      • 9.5.9.2 Financial performance
      • 9.5.9.3 Product benchmarking
      • 9.5.9.4 Strategic initiatives
    • 9.5.10 Douglas Pharmaceuticals Ltd.
      • 9.5.10.1 Company overview
      • 9.5.10.2 Financial performance
      • 9.5.10.3 Product benchmarking
      • 9.5.10.4 Strategic initiatives
    • 9.5.11 ENT Technologies Pty. Ltd.
      • 9.5.11.1 Company overview
      • 9.5.11.2 Financial performance
      • 9.5.11.3 Product benchmarking
      • 9.5.11.4 Strategic initiatives
    • 9.5.12 ENT Technologies Pty. Ltd.
      • 9.5.12.1 Company overview
      • 9.5.12.2 Financial performance
      • 9.5.12.3 Product benchmarking
      • 9.5.12.4 Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
  • Table 3 North America nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 4 North America nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 5 North America nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 6 North America nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 7 U.S. nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 8 U.S. nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 9 U.S. nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 10 U.S. nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 11 Canada nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 12 Canada nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 13 Canada nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 14 Canada nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 15 Europe nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
  • Table 16 Europe nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 17 Europe nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 18 Europe nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 19 Europe nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 20 Germany nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 21 Germany nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 22 Germany nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 23 Germany nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 24 U.K. nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 25 U.K. nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 26 U.K. nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 27 U.K. nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 28 France nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 29 France nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 30 France nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 31 France nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 32 Italy nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 33 Italy nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 34 Italy nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 35 Italy nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 36 Spain nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 37 Spain nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 38 Spain nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 39 Spain nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 40 Sweden nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 41 Sweden nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 42 Sweden nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 43 Sweden nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 44 Denmark nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 45 Denmark nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 46 Denmark nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 47 Denmark nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 48 Norway nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 49 Norway nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 50 Norway nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 51 Norway nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
  • Table 53 Asia Pacific nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 54 Asia Pacific nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 55 Asia Pacific nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 56 Asia Pacific nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 57 China nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 58 China nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 59 China nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 60 China nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 61 Japan nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 62 Japan nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 63 Japan nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 64 Japan nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 65 India nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 66 India nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 67 India nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 68 India nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 69 Australia nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 70 Australia nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 71 Australia nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 72 Australia nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 73 South Korea nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 74 South Korea nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 75 South Korea nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 76 South Korea nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 77 Thailand nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 78 Thailand nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 79 Thailand nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 80 Thailand nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 81 Latin America nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
  • Table 82 Latin America nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 83 Latin America nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 84 Latin America nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 85 Latin America nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 86 Brazil nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 87 Brazil nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 88 Brazil nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 89 Brazil nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 90 Mexico nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 91 Mexico nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 92 Mexico nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 93 Mexico nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 94 Argentina nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 95 Argentina nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 96 Argentina nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 97 Argentina nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 98 Middle East and Africa nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
  • Table 99 Middle East and Africa nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 100 Middle East and Africa nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 101 Middle East and Africa nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 102 Middle East and Africa nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 103 South Africa nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 104 South Africa nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 105 South Africa nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 106 South Africa nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 107 Saudi Arabia nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 108 Saudi Arabia nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 109 Saudi Arabia nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 110 Saudi Arabia nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 111 UAE nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 112 UAE nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 113 UAE nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 114 UAE nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 115 Kuwait nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 116 Kuwait nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 117 Kuwait nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 118 Kuwait nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Nasal drug delivery technology: market outlook
  • Fig. 14 Nasal drug delivery technology competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Nasal drug delivery technology driver impact
  • Fig. 20 Nasal drug delivery technology restraint impact
  • Fig. 21 Nasal drug delivery technology strategic initiatives analysis
  • Fig. 22 Nasal drug delivery technology: dosage form movement analysis
  • Fig. 23 Nasal drug delivery technology: dosage form outlook and key takeaways
  • Fig. 24 Nasal spray market estimates and forecast, 2018 - 2030
  • Fig. 25 Nasal drop market estimates and forecast, 2018 - 2030
  • Fig. 26 Nasal gel market estimates and forecast, 2018 - 2030
  • Fig. 27 Nasal powder market estimates and forecast, 2018 - 2030
  • Fig. 28 Nasal drug delivery technology: container type movement analysis
  • Fig. 29 Nasal drug delivery technology: container type outlook and key takeaways
  • Fig. 30 Pressurized containers market estimates and forecast, 2018 - 2030
  • Fig. 31 Non-pressurized containers market estimates and forecast, 2018 - 2030
  • Fig. 32 Nasal drug delivery technology: therapeutic application movement analysis
  • Fig. 33 Nasal drug delivery technology: therapeutic application outlook and key takeaways
  • Fig. 34 Nasal congestion market estimates and forecast, 2018 - 2030
  • Fig. 35 Rhinitis market estimates and forecast, 2018 - 2030
  • Fig. 36 Asthma market estimates and forecast, 2018 - 2030
  • Fig. 37 Others market estimates and forecast, 2018 - 2030
  • Fig. 38 Nasal drug delivery technology: distribution channel movement analysis
  • Fig. 39 Nasal drug delivery technology: distribution channel outlook and key takeaways
  • Fig. 40 Hospital pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 41 Retail pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 42 Online pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 43 Global nasal drug delivery technology market: regional movement analysis
  • Fig. 44 Global nasal drug delivery technology market: regional outlook and key takeaways
  • Fig. 45 Global market shares and leading players
  • Fig. 46 North America market share and leading players
  • Fig. 47 Europe market share and leading players
  • Fig. 48 Asia Pacific market share and leading players
  • Fig. 49 Latin America market share and leading players
  • Fig. 50 Middle East & Africa market share and leading players
  • Fig. 51 North America: SWOT
  • Fig. 52 Europe SWOT
  • Fig. 53 Asia Pacific SWOT
  • Fig. 54 Latin America SWOT
  • Fig. 55 MEA SWOT
  • Fig. 56 North America, by country
  • Fig. 57 North America
  • Fig. 58 North America market estimates and forecast, 2018 - 2030
  • Fig. 59 U.S.
  • Fig. 60 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 61 Canada
  • Fig. 62 Canada market estimates and forecast, 2018 - 2030
  • Fig. 63 Europe
  • Fig. 64 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 65 U.K.
  • Fig. 66 U.K. market estimates and forecast, 2018 - 2030
  • Fig. 67 Germany
  • Fig. 68 Germany market estimates and forecast, 2018 - 2030
  • Fig. 69 France
  • Fig. 70 France market estimates and forecast, 2018 - 2030
  • Fig. 71 Italy
  • Fig. 72 Italy market estimates and forecast, 2018 - 2030
  • Fig. 73 Spain
  • Fig. 74 Spain market estimates and forecast, 2018 - 2030
  • Fig. 75 Sweden
  • Fig. 76 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 77 Denmark
  • Fig. 78 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 79 Norway
  • Fig. 80 Norway market estimates and forecast, 2018 - 2030
  • Fig. 81 Asia Pacific
  • Fig. 82 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 83 China
  • Fig. 84 China market estimates and forecast, 2018 - 2030
  • Fig. 85 Japan
  • Fig. 86 Japan market estimates and forecast, 2018 - 2030
  • Fig. 87 India
  • Fig. 88 India market estimates and forecast, 2018 - 2030
  • Fig. 89 Australia
  • Fig. 90 Australia market estimates and forecast, 2018 - 2030
  • Fig. 91 South Korea
  • Fig. 92 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 93 Thailand
  • Fig. 94 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 95 Latin America
  • Fig. 96 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 97 Brazil
  • Fig. 98 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 99 Mexico
  • Fig. 100 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 101 Argentina
  • Fig. 102 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 103 Middle East and Africa
  • Fig. 104 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 105 Saudi Arabia
  • Fig. 106 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 107 South Africa
  • Fig. 108 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 109 UAE
  • Fig. 110 UAE market estimates and forecast, 2018 - 2030
  • Fig. 111 Kuwait
  • Fig. 112 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 113 Participant categorization- nasal drug delivery technology market
  • Fig. 114 Market share of key market players- nasal drug delivery technology market